Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?

Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?

Introduction: The renoprotective effect of renin-angiotensin (RAS) blockers (angiotensin converting enzyme inhibitors and angiotensin receptor blockers) has been questioned in patients with advanced chronic kidney disease (CKD). Moreover, combination therapy (dual RAS blockade) can further accelerat...

Full description

Bibliographic Details
Main Authors:	Fernando Caravaca-Fontán, Julián Valladares, Rosa Díaz-Campillejo, Sergio Barroso, Enrique Luna, Francisco Caravaca
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Nefrología (English Edition)
Online Access:	http://www.sciencedirect.com/science/article/pii/S2013251420300092

Similar Items

Association of hyperkalemia with clinical outcomes in advanced chronic kidney disease
by: Fernando Caravaca-Fontán, et al.
Published: (2019-09-01)

Renal potassium management in chronic kidney disease: Differences between patients with or without hyperkalemia
by: Fernando Caravaca-Fontán, et al.
Published: (2020-03-01)

Asociación entre hiperkaliemia y evolución clínica en la enfermedad renal crónica avanzada
by: Fernando Caravaca-Fontán, et al.
Published: (2019-09-01)

Efecto negativo del bloqueo del sistema renina-angiotensina sobre la progresión de la enfermedad renal crónica avanzada: ¿una cuestión de ajuste de dosis?
by: Fernando Caravaca-Fontán, et al.
Published: (2020-01-01)

Manejo renal del potasio en la enfermedad renal crónica avanzada: diferencias entre pacientes con o sin hipercaliemia
by: Fernando Caravaca-Fontán, et al.
Published: (2020-03-01)

Successful correction of metabolic acidosis is difficult to achieve inchronic kidney disease
by: Fernando Caravaca-Fontán, et al.
Published: (2020-05-01)

Acidosis metabólica en la enfermedad renal crónica: dificultades para una corrección adecuada
by: Fernando Caravaca-Fontán, et al.
Published: (2020-05-01)

Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension
by: Timothy WR Doulton, et al.
Published: (2009-12-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Overview of Regulation of the Renin–Angiotensin–Aldosterone System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

Renin–angiotensin system blockade for the risk of cancer and death
by: Jian Shen, et al.
Published: (2016-07-01)

Relative importance of the determinants of serum levels of 25-hydroxy vitamin D in patients with chronic kidney disease
by: Fernando Caravaca-Fontán, et al.
Published: (2016-09-01)

Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
by: Norman K Hollenberg
Published: (2001-03-01)

Effects of renin‐angiotensin blockade and APOL1 on kidney function in sickle cell disease
by: Jin Han, et al.
Published: (2021-08-01)

Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease
by: Yan-Huan Feng, et al.
Published: (2016-01-01)

Dual blockade of the renin-angiotensin system: are two better than one?
by: Haynes, R, et al.
Published: (2009)

Blockade of the renin-angiotensin-aldosterone system and renal protection in diabetes mellitus
by: Hans-Henrik Parving
Published: (2000-03-01)

Renoprotection in Type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers
by: Pauline A Swift, et al.
Published: (2001-09-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Characteristics and Usefulness of the Direct Renin Inhibitor Aliskiren
by: Atsuhiro Ichihara, et al.
Published: (2010-01-01)

How to assess the efficacy of phosphate binders
by: Francisco Caravaca, et al.
Published: (2017-05-01)

Cómo estimar la eficacia de un captor del fósforo
by: Francisco Caravaca, et al.
Published: (2017-05-01)

Cambios de la función renal tras la suspensión de análogos de vitamina D en la enfermedad renal crónica avanzada
by: Francisco Caravaca, et al.
Published: (2018-03-01)

The effect of renin–angiotensin system blockade on renal protection in chronic kidney disease patients with hyperkalemia
by: Ju-Hyun Lee, et al.
Published: (2014-12-01)

Acute Kidney Injury: An Acceptable Risk of Treatment with Renin-Angiotensin System Blockade in Primary Care?
by: Michael Bedford, et al.
Published: (2015-04-01)

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Mineralocorticoid-Receptor Blockers Exert Antihypertensive and Renoprotective Effects Independently of the Renin–Angiotensin System
by: Akira Nishiyama, et al.
Published: (2010-01-01)

Importancia relativa de los factores determinantes de los niveles séricos de 25-hidroxi-colecalciferol en la enfermedad renal crónica
by: Fernando Caravaca-Fontán, et al.
Published: (2016-09-01)

Review: Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment
by: Niels Holmark Andersen, et al.
Published: (2001-09-01)

Prognostic impact of renin-angiotensin system blockade in esophageal squamous cell carcinoma
by: Yen-Hao Chen, et al.
Published: (2015-12-01)

The dual blockade of the renin-angiotensin system in Internal Medicine: after ONTARGET trial
by: F. Rondoni, et al.
Published: (2013-05-01)

Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease
by: Mona A. Abdelrahman, et al.
Published: (2016-09-01)

Renin-Angiotensin-Aldosterone system blockade in diabetic kidney disease: A critical and contrarian point of view
by: Mohamed E Elrggal, et al.
Published: (2016-01-01)

The blockade of the renin-angiotensin system reverses tacrolimus related cardiovascular toxicity at the histopathological level
by: Mehmet Agirbasli, et al.
Published: (2007-06-01)

Combined renin-angiotensin system blockade and dietary sodium restriction impairs cardiomyocyte contractility
by: Petcharat Trongtorsak, et al.
Published: (2003-12-01)

Review: Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension
by: Joseph G Motwani
Published: (2002-06-01)

Multimodal Blockade of the Renin-Angiotensin System Is Safe and Is a Potential Cancer Treatment for Cats
by: John S. Munday, et al.
Published: (2022-08-01)

The association of renin–angiotensin system blockades and pneumonia requiring admission in patients with COPD
by: Kim J, et al.
Published: (2016-09-01)

High levels of both serum gamma-glutamyl transferase and alkaline phosphatase are independent predictors of mortality in patients with stage 4–5 chronic kidney disease
by: Fernando Caravaca-Fontán, et al.
Published: (2017-05-01)

Renin‐Angiotensin System Blockade in Aortic Stenosis: Implications Before and After Aortic Valve Replacement
by: Sachin S. Goel, et al.
Published: (2020-09-01)

Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction
by: Emad Abro, et al.
Published: (2001-03-01)

Blockade of the renin-angiotensin system for renal future perspectives protection: from history to future perspective
by: Michel Burnier
Published: (2007-12-01)

Effects of Renin–Angiotensin Blockade on the Components of Early Interstitial Expansion in Patients with Type 1 Diabetes
by: Zahrah Khan, et al.
Published: (2023-07-01)